Janux Therapeutics, Inc.
JANX
$23.70
$0.472.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 996.01M | 1.01B | 1.03B | 658.03M | 646.29M |
| Total Receivables | 5.69M | 5.59M | 5.38M | 4.45M | 12.06M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.85M | 3.61M | 3.11M | 3.84M | 3.59M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.01B | 1.02B | 1.03B | 666.32M | 661.94M |
|
|
|||||
| Total Current Assets | 1.01B | 1.02B | 1.03B | 666.32M | 661.94M |
| Net Property, Plant & Equipment | 23.15M | 23.83M | 24.15M | 25.06M | 26.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.51M | 3.61M | 3.70M | 3.64M | 3.46M |
| Total Assets | 1.03B | 1.05B | 1.06B | 695.02M | 691.41M |
|
|
|||||
| Total Accounts Payable | 3.48M | 2.35M | 4.03M | 2.46M | 1.25M |
| Total Accrued Expenses | 16.03M | 13.34M | 11.68M | 13.02M | 8.57M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.87M | 1.81M | 1.75M | 1.69M | 1.63M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 94.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 94.00K |
| Total Current Liabilities | 21.38M | 17.50M | 17.46M | 17.17M | 11.55M |
|
|
|||||
| Total Current Liabilities | 21.38M | 17.50M | 17.46M | 17.17M | 11.55M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 20.32M | 20.80M | 21.28M | 21.74M | 22.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 41.70M | 38.30M | 38.74M | 38.92M | 33.74M |
|
|
|||||
| Common Stock & APIC | 1.28B | 1.27B | 1.26B | 865.81M | 848.78M |
| Retained Earnings | -295.12M | -261.27M | -237.76M | -217.54M | -189.48M |
| Treasury Stock & Other | 3.75M | 3.76M | 2.16M | 7.83M | -1.62M |
| Total Common Equity | 990.52M | 1.01B | 1.02B | 656.10M | 657.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 990.52M | 1.01B | 1.02B | 656.10M | 657.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 990.52M | 1.01B | 1.02B | 656.10M | 657.68M |
|
|
|||||